Health, Beauty And Wellness News: FTC, ADM, Hain, CRN, Boston Therapeutics
This article is powered by The Rose Sheet
Executive Summary
AuraVie 'risk free' marketer enforcement closes; ADM makes second proibiotics move; Hain Celestial announces CEO succession plan; CRN updates guidelines on SARMs, caffeine; and Sugardown supplement added to Kathy Ireland band.
You may also be interested in...
Supplements For Disease-Related Nutrition Shaping Consumer Health Landscape
Sales of dietary supplements promoted for nutritional needs of diabetics are exploding as consumers seek non-drug products to deal with symptoms of the disease, says a consumer health analyst in a recent presentation. Consumer health products positioned to prevent disease are growing at a much faster rate globally than those formulas that treat ailments.
FDA Brews Two Caffeine Dosage Warnings Six Weeks After Guidance
The agency publishes warning letters to liquidcaffeine.com, operated by Liquid Caffeine Inc., and Dual Health Body & Mind Inc. explaining that some of their highly concentrated caffeine products are adulterated and a threat to public health.
SARMs Subject To Steroids Scheduling By DEA Under Hatch, Whitehouse Bill
The Utah Republican and Rhode Island Democrat sponsor legislation to make selective androgen receptor modulators subject to the same authority the Drug Enforcement Administration has to regulate anabolic steroids. Hatch said the SARMs Control Act of 2018 would "ensure that the DEA has the authority it needs to prevent abuse and diversion of these dangerous substances.”